✦ LIBER ✦

Histone deacetylases in control of skeletogenesis

✍ Scribed by Jennifer J. Westendorf

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 256 KB
Volume: 102
Category: Article
ISSN: 0730-2312
DOI: 10.1002/jcb.21486

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Skeletogenesis occurs continuously during the lifespan of vertebrate organisms. In development, the skeleton is patterned and modeled until each bone achieves its optimal shape and full size. During adults, the skeleton is remodeled to maintain strength and release calcium. The bone‐resorbing and bone‐forming activities of osteoclasts and osteoblasts, respectively, are tightly coupled to maintain optimal skeletal health; however, during aging and disease, these cells can become uncoupled, adversely affecting skeletal health and strength. Histone deacetylases have emerged as important regulators of endochondral bone formation, osteoblast maturation and osteoclast survival. Histone deacetylases are inhibited by small molecules that are approved and/or in clinical trials as cancer therapeutic drugs or anti‐epileptic agents. In this article, the roles of histone deacetylases and effects of histone deacetylase inhibitors on bone and cartilage cells are reviewed. J. Cell. Biochem. 102: 332–340, 2007. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Histone deacetylases, transcriptional co

Histone deacetylases, transcriptional control, and cancer

✍ W. Douglas Cress; Edward Seto 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

A key event in the regulation of eukaryotic gene expression is the posttranslational modification of nucleosomal histones, which converts regions of chromosomes into transcriptionally active or inactive chromatin. The most well studied posttranslational modification of histones is the acetylation of

Role of histone deacetylases in acute le

Role of histone deacetylases in acute leukemia

✍ Randy Fenrick; Scott W. Hiebert 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Accumulating evidence points to a connection between cancer and transcriptional control by histone acetylation and deacetylation. This is particularly true with regard to the acute leukemias, many of which are caused by fusion proteins that have been created by chromosomal translocations. Genetic re

Regulation of histone deacetylase activi

Regulation of histone deacetylase activities

✍ Nilanjan Sengupta; Edward Seto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

## Abstract Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl groups from lysine residues in both histone and non‐histone proteins. They play a key role in the regulation of gene transcription and many other biological processes involving chromatin. Significantly, recent

Roles of histone acetyltransferases and

Roles of histone acetyltransferases and deacetylases in gene regulation

✍ Min-Hao Kuo; C. David Allis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

Acetylation of internal lysine residues of core histone N-terminal domains has been found correlatively associated with transcriptional activation in eukaryotes for more than three decades. Recent discoveries showing that several transcriptional regulators possess intrinsic histone acetyltransferase

Targeting Histone Deacetylase in Cancer

Targeting Histone Deacetylase in Cancer Therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Targeting histone deacetylase in cancer

Targeting histone deacetylase in cancer therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

## Abstract Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors. Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive. A